Describir: The IQ-SET India Study: A Multicentric, Retrospective, Observational Data Analysis Evaluating the Safety, Efficacy, and Tolerability of InsuQuick® (Insulin Aspart 100 U/mL) in Subjects with Type 2 Diabetes Mellitus.